EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa

Lilishia Gounder iD, Aabida Khan, Justen Manasa iD, Richard Lessells iD, Andrew Tomita, Melendhran Pillay, Sontaga C Manyana iD, Subitha Govender, Kerri-Lee Francois, Pravi Moodley, Nokukhanya Msomi iD, Kerusha Govender iD und 4 weitere

Viruses · 19.10.2024 · 16 (10) · 1634

DOI: 10.3390/v16101634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 19.10.2024. Verfasst von Lilishia Gounder und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Genotype. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European & Developing Countries Clinical Trials Partnership (EDCTP), European & Developing Countries Clinical Trials Partnership (EDCTP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 drug resistance (HIVDR) impedes treatment and control of HIV-1, especially in high-prevalence settings such as KwaZulu-Natal (KZN) province, South Africa. This study merged routine HIV-1 genotypic resistance test (GRT) data with Geographic Information Systems coordinates to assess patterns and geographic distribution of HIVDR in KZN, among ART-experienced adults with virological failure. We curated 3133 GRT records generated between 1 January 2018 and 30 June 2022, which includes the early phase of dolutegravir (DTG) rollout, of which 2735 (87.30%) had HIVDR. Of the 2735, major protease, nucleoside, and non-nucleoside reverse transcriptase inhibitor mutations were detected in 41.24%, 84.97% and 88.08% of GRTs, respectively. Additional genotyping of HIV-1 integrase for 41/3133 (1.31%) GRTs showed that 17/41 (41.46%) had integrase strand transfer inhibitor resistance. Notably, of 26 patients on DTG with integrase genotyping, 9 (34.62%) had DTG-associated resistance mutations. Dual- or triple-class resistance was observed in four of every five GRTs. The odds of HIVDR increased significantly with age, with ≥60 years having 5 times higher odds of HIVDR compared to 18–29 years (p = 0.001). We identified geospatial differences in the burden of HIVDR, providing proof of concept that this could be used for data-driven public health decision making. Ongoing real-time HIVDR surveillance is essential for evaluating the outcomes of the updated South African HIV treatment programme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralGenotypeAnti-HIV AgentsHumansSouth AfricaAdultFemaleMaleMutationDiagnostic Tests, RoutineMiddle AgedYoung AdultAdolescentPyridonesOxazinesHeterocyclic Compounds, 3-RingPiperazinesDolutegravir

Stichwörter der Autor:innen

HIV-1KwaZulu-NatalSouth Africadolutegravirdrug resistancegenotypic susceptibility scoresgeospatial analysis

Substanzen

Anti-HIV AgentsPyridonesOxazinesHeterocyclic Compounds, 3-RingPiperazinesDolutegravir

Autor:innen und Institutionen

  • Department of Virology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
  • Department of Virology, National Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.
  • Department of Oncology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Mount Pleasant, Harare P.O. Box MP 167, Zimbabwe.
  • KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
  • Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
  • Centre for Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban 4001, South Africa.

ORCID-Profile: Lilishia Gounder, Justen Manasa, Richard Lessells, Sontaga C Manyana, Nokukhanya Msomi, Kerusha Govender, Raveen Parboosing, Sikhulile Moyo, Kogieleum Naidoo

Förderung

  • European & Developing Countries Clinical Trials Partnership (EDCTP)
  • European & Developing Countries Clinical Trials Partnership (EDCTP)

Zitieren

APA

Gounder, L., Khan, A., Manasa, J., Lessells, R., Tomita, A., Pillay, M., Manyana, S. C., Govender, S., Francois, K. L., Moodley, P., Msomi, N., Govender, K., Parboosing, R., Moyo, S., Naidoo, K., & Chimukangara, B. (2024). Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa. Viruses, 16(10), 1634. https://doi.org/10.3390/v16101634

Vancouver

Gounder L, Khan A, Manasa J, Lessells R, Tomita A, Pillay M, et al. Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa. Viruses. 2024;16(10):1634. doi:10.3390/v16101634

BibTeX
@article{Gounder2024,
  author = {Gounder, Lilishia and Khan, Aabida and Manasa, Justen and Lessells, Richard and Tomita, Andrew and Pillay, Melendhran and Manyana, Sontaga C and Govender, Subitha and Francois, Kerri-Lee and Moodley, Pravi and Msomi, Nokukhanya and Govender, Kerusha and Parboosing, Raveen and Moyo, Sikhulile and Naidoo, Kogieleum and Chimukangara, Benjamin},
  title = {Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1634},
  doi = {10.3390/v16101634}
}
Kostenlos starten →